Skip to content

Detection of CardioRespiratory Events Using Acoustic Monitoring in Preterm Infants on CPAP

Detection of CardioRespiratory Events Using Acoustic Monitoring in Preterm Infants on Continuous Positive Airway Pressure: the DREAM Pilot Project

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05196646
Acronym
DREAM
Enrollment
50
Registered
2022-01-19
Start date
2022-12-05
Completion date
2026-12-31
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Apnea of Prematurity

Keywords

Airflow, Apnea, Cardiorespiratory events, Monitoring, Neonatal Intensive Care, Preterm infants, Respiratory acoustics, Prematurity, CPAP, Acoustic monitoring

Brief summary

This is an observational, proof-of-concept, feasibility study where 50 preterm infants with gestational age \< 32+0 weeks will be recruited from the neonatal intensive care unit (NICU) at the Montreal Children's Hospital. The study's primary objective is to describe the relationship between respiratory acoustics and airflow and determine the reliability of a novel respiratory acoustic sensor at detecting breathing sounds in preterm infants. The study's secondary objectives are: 1. To compare transthoracic impedance, respiratory inductive plethysmography and an inertial measurement unit for the detection of respiratory efforts in preterm infants. 2. To evaluate the feasibility and accuracy of a novel, non-invasive method for continuously detecting and differentiating cardiorespiratory events in preterm infants on CPAP by integrating measurements of respiratory effort with respiratory acoustic monitoring.

Detailed description

Cardiorespiratory events, defined by the occurrence of apneas, bradycardias, and desaturations, are almost ubiquitous in very preterm infants and are associated with numerous complications. Unfortunately, the current standard for monitoring cardiorespiratory events in the NICU, transthoracic impedance (TTI), does not permit for accurate differentiation of the different types of cardiorespiratory events; TTI cannot detect airflow and has low accuracy for detecting respiratory efforts. As a result, TTI does not detect obstructive apneas and may not reliably capture all central apneas. Respiratory sounds are an attractive surrogate measure of airflow, and can be captured using respiratory acoustic technology (akin to a miniaturized electronic stethoscope). We hypothesize that respiratory acoustic monitoring can provide a continuous, non-invasive, and accurate representation of airflow and breathing sounds in preterm infants. Altogether, we conjecture that the combination of respiratory acoustic monitoring with measurements of respiratory effort will improve the ability to differentiate and describe the nature of cardiorespiratory events in preterm infants.

Interventions

DEVICERespiratory Acoustic Sensors

Wireless sensor that contains a dual microphone and an inertial measurement unit (IMU) will capture the breathing sound and respiratory effect. Two wireless sensors will be used, with one placed on the suprasternal notch and the other placed on the right upper chest of the infant, in order to determine the sensor placement yielding the best respiratory signal. Data will be transmitted in real-time to a research-dedicated tablet using the Bluetooth Communication Controller (ISP1807, Insight SIP) and stored on the same device for future analysis.

DEVICENasal thermistor

The nasal temperature probe that detects changes in temperature between inhaled and exhaled gases allows for the surrogate measure of airflow. It will be placed in one naris and secured with tape at the upper lip or cheek. The nasal temperature signal will be acquired using the Power Lab analog-digital acquisition system and stored for later analysis.

Two respiratory bands will be placed circumferentially around the infant's chest (at the level of nipple line) and around the abdomen (just above the level of the umbilicus) in order to measure chest and abdominal wall movements, respectively. These movements will be recorded using Respiratory Inductive Plethysmography (Respitrace QDC®, Viasys® Healthcare, USA). The Respitrace® signals will be acquired using the Power Lab data acquisition system and stored for later analysis.

DEVICEPneumotachometer

The pneumotachometer is a pressure-differential based flow sensor that is used to measure respiratory flow. It will be connected to a standard face mask that is gently applied to cover the infant's mouth and nose. The face mask will be similar to the masks used as part of standard of care in the NICU for infants who require continuous positive pressure, with or without ventilation. The flow measurements will be recorded using the Power Lab data acquisition system and stored for later analysis.

Sponsors

McGill University Health Centre/Research Institute of the McGill University Health Centre
Lead SponsorOTHER
Northwestern University
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
72 Years to No maximum
Healthy volunteers
No

Inclusion criteria

for all infants: * Gestational age \< 32+0 weeks * Postmenstrual age between 28+0 and 36+6 weeks. Additional inclusion criteria for Groups 1 and 2: * Off any respiratory support and breathing in-room air * Less than 3 clinically significant cardiorespiratory events per calendar day Additional inclusion criteria for Group 3: * On the bubble CPAP device with the binasal prongs interface * Receiving CPAP levels of 5 to 7 cm H2O with gas flows not exceeding 10L/min * At least 3 clinically significant cardiorespiratory events per calendar day

Exclusion criteria

* Major known congenital abnormalities * Known congenital heart disorders * Known neuromuscular disease * Known diaphragmatic paralysis or a diagnosed phrenic nerve injury * History of esophageal perforation in the 7 days preceding the study * History of pneumothorax requiring chest tube insertion in the 7 days preceding the study * Receiving inotropes, narcotics, or sedative agents at the time of study recording Additional exclusions at the time of the study recording: * Infants receiving ventilator-derived CPAP * Infants receiving CPAP via a nasal mask interface. * Infants receiving inotropes, narcotics or sedative agents * Infants deemed clinically unstable for the study by the attending neonatologist.

Design outcomes

Primary

MeasureTime frameDescription
Reliability of respiratory acoustics at detecting airflow compared to airflow measurements obtained from a pneumotachometer.10 minutes (group 1) or 3 hours (groups 2 and 3)The airflow signal derived from the respiratory acoustic sensor will be compared with the airflow signal derived from the pneumotachometer.

Secondary

MeasureTime frameDescription
Reliability of the inertial measurement unit (IMU) at detecting respiratory efforts compared to Respiratory Inductance Plethysmography (RIP).3 hours (groups 2 and 3 only)The chest wall movement signal derived from the respiratory acoustic sensor will be compared with the chest wall movement signal derived from RIP.
Reliability of the inertial measurement unit (IMU) at detecting respiratory efforts compared to Transthoracic Impedance (TTI).3 hours (groups 2 and 3 only)The chest wall movement signal derived from the respiratory acoustic sensor will be compared with the chest wall movement signal derived from TTI.

Countries

Canada

Contacts

PRINCIPAL_INVESTIGATORWissam M Shalish, MD PhD

McGill University Health Centre/Research Institute of the McGill University Health Centre

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 31, 2026